Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€11.68
13.11.20
€12.00
3.42%
18.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Traumtanz 
13.11.20 50%
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€60.99
13.11.20
€63.00
6.59%
14.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Traumtanz 
13.11.20 50%
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€59.80
13.11.20
€60.00
1.99%
13.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Traumtanz 
13.11.20 50%
buy
OceanaGold Corp.

Start price
Target price
Perf. (%)
€1.20
13.11.20
€2.00
13.11.21
60.00%
14.11.21

Could be very worthwhile Investment >20% year
Lions_Investments 
13.11.20 50%
buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€11.18
12.11.20
€13.00
4.47%
13.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Traumtanz 
12.11.20 50%
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€57.49
12.11.20
€60.00
4.02%
13.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Traumtanz 
12.11.20 50%
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€54.30
12.11.20
€57.00
5.87%
12.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Traumtanz 
12.11.20 50%
buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€10.98
12.11.20
€12.00
1.82%
12.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Traumtanz 
12.11.20 50%
buy
Maisons du Monde SAS

Start price
Target price
Perf. (%)
€12.59
12.11.20
€22.00
12.11.21
66.00%
13.11.21

Could be worthwhile Investment >10% per year
melinda 
12.11.20 40%
buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€10.08
11.11.20
€12.00
3.57%
11.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Traumtanz 
11.11.20 50%
buy
Noratis AG

Start price
Target price
Perf. (%)
€17.70
11.11.20
€24.00
11.11.21
2.26%
14.11.20

Covacoro 
11.11.20 50%
buy
Aurelius AG

Start price
Target price
Perf. (%)
€15.96
10.11.20
-
10.11.21
15.91%
21.01.21

Future proof or reliable business model
Higher risks for its business
Little known brand
OldOrangeEyes 
10.11.20 50%
buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€8.78
10.11.20
€9.00
15.26%
11.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Traumtanz 
10.11.20 50%
buy
Steico SE

Start price
Target price
Perf. (%)
€50.20
10.11.20
€55.00
1.99%
01.12.20

Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Traumtanz 
10.11.20 50%
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€50.44
10.11.20
€55.00
4.48%
12.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Traumtanz 
10.11.20 50%
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€48.01
10.11.20
€55.00
5.07%
10.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Traumtanz 
10.11.20 50%
buy
Nel ASA

Start price
Target price
Perf. (%)
€1.77
10.11.20
€2.00
10.11.21
4.79%
12.07.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Mefospoon 
10.11.20 50%
buy
Nidec Corp.

Start price
Target price
Perf. (%)
€94.56
09.11.20
€105.00
2.18%
25.11.20

Future proof or reliable business model
Traumtanz 
09.11.20 50%
buy
AT&S Austria Technologie & Systemtechnik AG

Start price
Target price
Perf. (%)
€18.34
08.11.20
-
0.55%
14.11.20

Covacoro 
08.11.20 50%
buy
Kontron AG

Start price
Target price
Perf. (%)
€18.26
08.11.20
€26.00
08.11.21
4.93%
14.11.20

Covacoro 
08.11.20 50%
buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.15
08.11.20
€5.00
08.11.21
-29.28%
09.11.21

Could be worthwhile Investment >10% per year
melinda 
08.11.20 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.30
07.11.20
-
07.11.21
15.65%
15.07.21

Probably not worthwhile Investment
Biotechhunter 
07.11.20 50%
sell
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€5.80
07.11.20
-
07.11.21
-0.34%
15.07.21

Could be very worthwhile Investment >20% year
Biotechhunter 
07.11.20 50%
sell
Sfc Energy AG

Start price
Target price
Perf. (%)
€14.64
05.11.20
-
05.11.21
14.21%
18.01.21

Outdated or very high risk business model
High risks for its business
Risky Investment
ElectricPlayer 
05.11.20 50%
sell
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.50
05.11.20
-
05.11.21
47.44%
06.11.21

marge 
05.11.20 50%